People living with motor neurone disease (MND) can now create bespoke digital artwork through an artificial intelligence (AI) art platform...
Specialists at Eximius explore the condition, its impact, and care options available
Professor Dame Pamela Shaw joins to help advance development of its ALS/MND drug candidate SAM001
NR Times reports on the much-anticipated trial of ALS treatment AMX0035, in an interview with Machelle Manuel, head of global medical affairs at its creator Amylyx. Recently...
Cavendish Homecare discuss MND and the importance of planning for the disease in the final stages
Motor Neurone Disease research has long been underfunded, but the pathway towards better treatments – and potentially a cure – seems within reach. Over 2000 people...
Researchers have shown “top-line” results from the phase 2b trial of low dose Interleukin-2 (ld IL2) in MND patients. The MIROCALS (Modifying Immune Response and Outcomes...
Findings prompt MND Association to launch campaign calling on government to undertake a full review of carers’ assessments
A new clinic has been created to offer additional dysphagia interventions
Risk of dementia is twice as high as general population, rising to up to 15 times as high for MND, shocking new study reveals
